Planning and evaluation activities have played a key role in the growth and steady improvement of KUCC. Multiple internal committees including KUCC Leadership Council and Associate Directors Council guide the planning and evaluation process under the leadership of Director Jensen and in coordination with the External Advisory Board (EAB). The EAB serves a critical role in providing external oversight of planning and evaluation of KUCC vision, direction, leadership, research programs, and supporting infrastructure. The EAB was selected by KUCC leadership to match our research programs, shared resources and administrative components. The EAB has made numerous major recommendations such as defining the relationship between the KU Hospital and KUCC, increasing the number of patients on therapeutic trials, suggesting a timeline for the PSO application, suggesting ways to tighten membership criteria, expanding the number of NCI funded investigators, better integrating with the Stowers Institute for Medical Research, integrating clinicians into the Drug Discovery, Delivery and Experimental Therapeutics Program, and improving the KUCC website. KUCC Leadership Council promotes scientific interactions between the basic, translational, and clinical elements of the Center, plans development of the research programs, leverages KUCC resources for maximum benefit, and oversees activities of KUCC programs. The Associate Directors Council evaluates cross-program activities including symposia, seminars and conferences, allocations of pre-and post-doctoral trainee stipends and KUCC pilot research grants, and new research membership applications as well as conducts an annual review of membership. Each year the Associate Directors Council reviews the progress of the research programs, shared resources and administrative functions of KUCC. The KUCC-ADC makes final recommendations to the Director on practically all issues including budget, resource allocation, membership, space, leadership appointments, and strategic direction. The MCA Partners Advisory Board promotes collaboration of key hospitals and research institutions in the areas of research and education and advises the Cancer Center Director on the impact of KUCC in the community.

Public Health Relevance

Planning and evaluation activities have clearly been an essential component of our continued and steady improvement over the last seven years and will continue to play a critical role in the future. KUCC's External Advisory Board and key internal advisory groups have played important roles in this activity and this has resulted in a vigorous and robust process of envisioning our potential, thoughtful reflection, and proactive change management.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Kansas
Kansas City
United States
Zip Code
Jiang, Yu; Simon, Steve; Mayo, Matthew S et al. (2015) Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors. Stat Med 34:613-29
Zeineldin, Maged; Jensen, Derek; Paranjape, Smita R et al. (2014) Human cancer xenografts in outbred nude mice can be confounded by polymorphisms in a modifier of tumorigenesis. Genetics 197:1365-76
Winham, Stacey J; Armasu, Sebastian M; Cicek, Mine S et al. (2014) Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer. Genet Epidemiol 38:457-66
Block, Matthew S; Charbonneau, Bridget; Vierkant, Robert A et al. (2014) Variation in NF-?B signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 23:1421-7
Pessetto, Ziyan Y; Ma, Yan; Hirst, Jeff J et al. (2014) Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor. Mol Cancer Ther 13:2276-87
Purrington, Kristen S; Slager, Susan; Eccles, Diana et al. (2014) Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis 35:1012-9
Bohl, Christopher R; Harihar, Sitaram; Denning, Warren L et al. (2014) Metastasis suppressors in breast cancers: mechanistic insights and clinical potential. J Mol Med (Berl) 92:13-30
Peterson, Kenneth R; Costa, Flávia C; Fedosyuk, Halyna et al. (2014) A cell-based high-throughput screen for novel chemical inducers of fetal hemoglobin for treatment of hemoglobinopathies. PLoS One 9:e107006
Meneely, Kathleen M; Luo, Qianyi; Riley, Andrew P et al. (2014) Expanding the results of a high throughput screen against an isochorismate-pyruvate lyase to enzymes of a similar scaffold or mechanism. Bioorg Med Chem 22:5961-9
Osorio, Ana; Milne, Roger L; Kuchenbaecker, Karoline et al. (2014) DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. PLoS Genet 10:e1004256

Showing the most recent 10 out of 26 publications